Abstract
Objective: To determine the need of total thyrodectomy for patients with follicular nodules of thyroid. Subjects and methods: From January 2005 through June 2008, 2249 consecutive patients (438 males, 1811 females; mean age 54 yr, range 9–87) with thyroid nodules were submitted to 2518 ultrasound-guided fine-needle aspiration (USgFNA) for cytological examination. USgFNA were performed by experienced surgeon (RP) and endocrinologist (RGG) under ultra-sonographyc guidance, using a 10-MHz linear transducer. Liquid-based cytology was used. Results: All cytological samples were classified in 5 diagnostic classes (THY1, THY2, THY3, THY4, THY5) in agreement with the British Thyroid Association (BTA); 1.4% specimen were classified as THY5, 2.1 % as THY4, 7.6% as THY3, 79.5% as THY2 and 9.4% as THY1. In 97% of THY5 patients, malignancy was found. Among THY4 patients, 95.5% were positive for thyroid tumor. Among THY3 patients, malignancy was found in 29.1%. THY3 patients with thyroid tumors were younger than those with benign lesions (46±14.1 yr vs 50±13.8 yr; p<0.05, t test). No statistical difference was found neither in malignancy frequency among men and women nor in mean size of nodules (24±11.8 mm malignant vs 23 ± 9.4 mm benign). Conclusions: this study provides evidence that USgFNA offers a very sensitive and accurate method in reducing THY1 samples and in detecting malignancy (>95% both in THY5 and THY4, and >29% in THY3 lesions). Our proposal is to submit to total thyroidectomy all patients with THY5 and THY4 lesions and THY3 thyroid nodule >1 cm.
Similar content being viewed by others
References
Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008, 22: 901–11.
Tan GH, Gharib H. Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997, 126: 226–31.
Hoang JK, Lee WK, Lee M, Johnson D, Farrell S. US features of thyroid malignancy: pearls and pitfalls. Radiographics 2007, 27: 847–65.
Pisani T, Bononi M, Nagar C, Angelini M, Bezzi M, Vecchione A. Fine-needle aspiration and core needle biopsy techniques in the diagnosis of nodular thyroid pathologies. Anticancer Res 2000, 20: 3843–7.
Operator’s Manual. ThinPrep Processor. Marlborough, Ma: Cytyc Corporation, 1992.
Poller DN, Ibrahim AK, Cummings MH, Mikel JJ, Boote D, Perry M. Fine needle aspiration of the thyroid. Importance of an indeterminate diagnostic category. Cancer 2000, 90: 239–44.
Anderson CE, McLaren KM. Best practice in thyroid pathology. J Clin Pathol 2003, 56: 401–5.
Gruppo di lavoro SIAPEC-IAP 2007. Consenso Italiano sulla Gestione Clinica del paziente con Patologia Nodulare Tiroidea. Available at www.siapec.it, accessed October 10, 2007.
British Thyroid Association, Royal College of Physicians. Guidelines for the management of thyroid cancer. In: Perros P. ed. Report of the Thyroid Cancer Guidelines Update Group. 2nd edition. London: Royal College of Physicians, 2007.
Heidinger CHR, Sobin IH. Histopathological typing of thyroid tumors. Roto-Sadag sa, ed. International histological classification of tumors. Geneva: WHO; col 11. 1974, 17–27.
Scurry JP, Duggan MA. Thin layer compared to directsmear in thyroid fine-needle aspiration. Cytopathology 2000, 11: 104–15.
Lee KR, Papillo JL, St John T, Eyerer GJ. Evaluation of the Thin Prep processor for fine needle aspiration specimens. Acta Cytol 1996, 40: 895–9.
Biscotti CV, Hollow JA, Toddy SM, Easley KA. ThinPrep versus conventional smear cytologic preparations in the analysis of thyroid fine-needle aspiration specimens. Am J Clin Pathol 1995, 104: 150–3.
Frost AR, Sidawy MK, Ferfelli M, et al. Utility of thin-layer preparations in thyroid fine-needle aspiration: diagnostic accuracy, cytomorphology, and optimal sample preparation. Cancer 1998, 84: 17–25.
Fadda G, Rossi ED, Raffaelli M, et al. Fine-needle aspiration biopsy of thyroid lesions processed by thin-layer cytology: one-year institutional experience with histologic correlation. Thyroid Oct 2006, 16: 975–81.
Gharib H, Papini E. Thyroid nodules: clinical importance, assessment and treatment. Endocrinol Metab Clin North Am 2007, 36: 707–35.
Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of follicular neoplasm: a gray zone in thyroid fine-needle aspiraction cytology. Diagn Cytopathol 2002, 26: 41–4.
Baloch ZW, LiVolsi VA. The quest for a magic tumor marker: continuing saga in the diagnosis of the follicular lesions of thyroid. Am J Clin Pathol 2002, 118: 165–6.
Mihai R, Parker AJ, Roskell D, Sadler GP. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma. Thyroid 2009, 19: 33–7.
Yang GC, Liebeskind, Messina AV. Should cytopathologists stop reperting follicular neoplasms on fine needle aspiration of the thyroid? Cancer 2003, 99: 69–74.
Rossi ED, Morassi F, Santeusanio G, Zannoni GF, Fadda G. Thyroid fine needle aspiration cytology processed by ThinPrep: an additional slide decreased the number of inadequate results. Cytopathology, 21: 97–102.
Sorrenti S, Trimboli P, Catania A, Ulisse S, De Antoni E, D’Armiento M. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hurthle cell neoplasm. Thyroid 2009, 19: 355–60.
Foppiani L, Tancredi M, Ansaldo GL, Ceppa P, Auriati L, Torre GC, Minuto F, Giusti M. Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration. J Endocrinol Invest 2003, 26: 29–34.
Scott-Combes D. Audit of the British Association of Endocrine Surgeons-2007 Report. London: Dendrite.
Schlinkert RT, Van Heerden JA, Goellner JR, et al. Factors that predict malignant thyroid lesions when fine-needle aspiration is ‘suspicious for follicular neoplasm.’. Mayo Clin Proc 1997, 72: 913–6
Theoharis CGA, Schofield KM, Hammers L, Udelsman R, Chhieng DC. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 2009, 19: 1215–23.
Tuttle RM, Lemar H, Burch HB. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998, 8: 377–83.
Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z. Does the fine-needle aspiration diagnosis of “Hurthle-cell neoplasm/follicular neoplasm with oncocytic features” denote increased risk of malignancy? Diagn Cytopathol 2004, 31: 307–12
Greaves TS, Olvera M, Florentine BD, et al. Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer 2000, 90: 335–41.
Trimboli P, Condorelli E, Catania A, Sorrenti S. Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm. Diagn Cytopathol 2009, 37: 783–5.
Rago T, Santini F, Scutari M, Pinchera A, Vitti P. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab 2007, 92: 2917–22.
Sebastianes FM, Cerci JJ, Zanoni PH, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab 2007, 92: 4485–8.
Alexander EK. Approach to the patient with a cytologically indeterminate thyroid nodule. J Clin Endocrinol Metab 2008, 93: 4175–82.
Mazzanti C, Zeiger MA, Costouros NG, et al. Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 2004, 64: 2898–903.
Kebebew E, Peng M, Reiff E, McMillan A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 2006, 106: 2592–7.
Shibru D, Hwang J, Khanafshar E, Duh QY, Clark OH, Kebebew E. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms? Cancer 2008, 113: 930–5.
Gharib H, Papini E, Valcavi R, et al; AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006, 12: 63–102.
Makay O, Icoz G, Gurcu B, et al. The ongoing debate in thyroid surgery: should frozen section analysis be omitted? Endocr J 2007, 54: 385–90.
Paphavasit A, Thompson GB, Hay ID, et al. Follicular and Hürthle cell thyroid neoplasms. Is frozen-section evaluation worthwhile? Arch Surg 1997, 132: 674–8.
Duek SD, Goldenberg D, Linn S, Krausz MM, Hershko DD. The role of fine-needle aspiration and intraoperative frozen section in the surgical management of solitary thyroid nodules. Surg Today 2002, 32: 857–61.
Wong Z, Muthu C, Craik J, Carter J, Harman CR. Role of intraoperative frozen section in the management of thyroid nodules. ANZ J Surg 2004, 74: 1052–5.
Richards ML, Chisholm R, Bruder JM, Strodel WE. Is thyroid frozen section too much for too little? Am J Surg 2002, 184: 510–4.
Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006, 154: 787–803
Rago T, Di Coscio G, Basolo F, et al. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hurthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) 2007, 66: 13–20.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gheri, R.G., Romoli, E., Vezzosi, V. et al. Follicular nodules (THY3) of the thyroid: We recommend surgery. J Endocrinol Invest 34, e183–e187 (2011). https://doi.org/10.3275/7416
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3275/7416